Troubled Allegheny Cuts Cancer Programs; Institution Holds Grants for NSABP, ECOG
In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death
Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial
NCI Programs: Advisors Approve Plans For New Grants In Imaging Research
HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
